
A study on benzoyl peroxide (BPO) in dermatological aesthetics found that most adverse reactions, such as swelling, pain, and burning, affect the skin. EPSOLAY (5% microencapsulated BPO) caused erythema, pruritus, and exfoliation without tumor-related reports. The findings emphasize the need for improved safety measures and patient education, especially due to the risk of BPO decomposing into benzene.
Like
Save
Share